F215-0127 Screening compound: N-(4-{7-METHYLIMIDAZO[1,2-A]PYRIMIDIN-2-YL}PHENYL)-3-(TRIFLUOROMETHYL)BENZAMIDE

F215-0127 Screening compound: N-(4-{7-METHYLIMIDAZO[1,2-A]PYRIMIDIN-2-YL}PHENYL)-3-(TRIFLUOROMETHYL)BENZAMIDE
F215-0127 Screening compound: N-(4-{7-METHYLIMIDAZO[1,2-A]PYRIMIDIN-2-YL}PHENYL)-3-(TRIFLUOROMETHYL)BENZAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound F215-0127
N-(4-{7-METHYLIMIDAZO[1,2-A]PYRIMIDIN-2-YL}PHENYL)-3-(TRIFLUOROMETHYL)BENZAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F215-0127

Molecular Formula

C21H15F3N4O (C21 H15 F3 N4 O)

Compound Name

N-(4-{7-METHYLIMIDAZO[1,2-A]PYRIMIDIN-2-YL}PHENYL)-3-(TRIFLUOROMETHYL)BENZAMIDE

IUPAC name

N-(4-{7-methylimidazo[12-a]pyrimidin-2-yl}phenyl)-3-(trifluoromethyl)benzamide

SMILES

Cc1nc2nc(-c(cc3)ccc3NC(c3cccc(C(F)(F)F)c3)=O)cn2cc1

InChI

InChI=1S/C21H15F3N4O/c1-13-9-10-28-12-18(27-20(28)25-13)14-5-7-17(8-6-14)26-19(29)15-3-2-4-16(11-15)21(22,23)24/h2-12H,1H3,(H,26,29)

InChI Key

LJJIGXBPVJVQPB-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD08535846

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

396.37

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

4.349

Distribution Coefficient, logD

4.346

Water Solubility, LogSw

-4.34

Polar Surface Area

42.575

Acid Dissociation Constant (pKa)

10.95

Base Dissociation Constant (pKb)

5.23

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

9.50

F215-0127 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Protein-Protein Interaction Library (218420 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

SmartTM Library (51161 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Mechanism of action:
  • PPI modulators
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with F215-0127 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F215-0127?
Check Price and Availability of F215-0127, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F215-0127 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F215-0127
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F215-0127
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F215-0127 available by request